Vitrolife AB (publ) (VITR.ST)
Stockholm · SEK · Healthcare · Medical Devices
SEK 112.90 (+0.98%) as of
Key statistics
- Market cap
- 14.98B
- Forward P/E
- 23.47
- EPS (TTM)
- -36.60
- Dividend yield
- 0.98%
- 52-week range
- 84.00 – 152.50
- Beta
- 1.67
- Revenue (TTM)
- 3.44B
- Profit margin
- -144.10%
- Analyst target
- SEK 133.00
- Volume
- 377.10k
About Vitrolife AB (publ)
Vitrolife AB (publ) provides assisted reproduction products in Europe, the Middle East, Africa, Asia-Pacific, and the Americas. It offers sperm processing, oocyte retrieval needles, micromanipulation pipettes, time-lapse systems, and evaluation tools, laser and imaging systems, IVF media and oil, embryo transfer, cryopreservation, and genomics kits. The company also provides eWitness and Labware products, such as dishes, pipettes, tubes, and VitroTemp. The company was incorporated in 1989 and is based in Gothenburg, Sweden.
- Sector
- Healthcare
- Industry
- Medical Devices
- Headquarters
- Gothenburg, Sweden
- Employees
- 1,088
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.